For the executive director of the Serum Institute of India, Adar Poonawalla, the moment of happy new year came on January 3 after the General Controller of Drugs of India on Sunday gave the final go-ahead to Covishield, the vaccine developed by the Oxford University and leading pharmaceutical Astrazeneca and …
Read More »
Moderna Inc has teamed up with Pfizer Inc to apply to the FDA to issue an emergency use authorization for its injection. Both vaccines are more than 90% effective, according to preliminary results from clinical trials. “Moderna’s data for the emergency use authorization request for mRNA-1273 has been submitted to …
Read More »
On Wednesday, the government launched the ‘COVID Suraksha Mission’, which will assist the development process of approximately five to six Covid-19 vaccine candidates. Starting from the research and development part of the vaccines, the mission will help them obtain the license and finally bring them to the market. Since several …
Read More »
The dream run of national stocks reached a new pinnacle on Tuesday when the Nifty50 index surpassed the 13,000 mark for the first time. Meanwhile, the S&P BSE Sensex topped the 44,500 mark in intraday deals. A better-than-expected profit cocktail, better collection of goods and services tax (GST), better big …
Read More »
US-based Moderna expects interim results from its covid vaccine trials next month. And if the company gets interim positive results from the large clinical trial, the US government could authorize emergency use of the company’s experimental Covid-19 vaccine in December, its chief executive said. During The Wall Street Journal’s annual …
Read More »
The Comptroller General of Drugs of India has rejected the proposal of the laboratories of the pharmaceutical company Dr. Reddy to carry out the third phase trial of the Sputnik V vaccine from Russia, since the first trials have been conditional on a small group of population abroad. After Russia …
Read More »
Some covid vaccine developers may publish interim data from their end-stage trials over the next several weeks. There is no approved COVID-19 vaccine yet, but several are in advanced trials, including those by Pfizer Inc, Johnson & Johnson, AstraZeneca-Oxford University, Novavax, and Moderna. Pfizer and its partner BioNTech could have …
Read More »
A day after questioning India’s financial plan to purchase and distribute the Covid-19 vaccine, Serum Institute of India Executive Director Adar Poonawalla has praised Prime Minister Narendra Modi’s vision of providing vaccines to the global community. We share and applaud your vision @Narendra Modi hee, about supplying vaccines to the …
Read More »
China reported some positive results in the phase 3 trial of a Covid-19 vaccine, said Chinese Foreign Ministry spokesman Wang Wenbin. The UAE, which is part of the phase 3 trial of this Chinese vaccine, has also reported positive results. Several vaccine trials are currently underway. This is all you …
Read More »
Pfizer Inc and BioNTech SE have proposed to authorities to expand their Phase 3 COVID-19 vaccine trial to approximately 44,000 participants while increasing the diversity of the trial population. The initial target figure for the covid vaccine trial that the two companies are jointly developing was up to 30,000 participants, …
Read More »